SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001818382-24-000042
Filing Date
2024-03-28
Accepted
2024-03-28 08:55:15
Documents
5
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 huma20240328s-8.htm S-8 54299
2 EX-FILING FEES huma20240328s-8xex107.htm EX-FILING FEES 18342
3 EX-5.1 huma20240328s-8xex51.htm EX-5.1 7171
4 EX-23.2 huma20240328s-8ex232.htm EX-23.2 2494
5 letterhead.jpg GRAPHIC 14892
  Complete submission text file 0001818382-24-000042.txt   103435
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278296 | Film No.: 24793863
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)